Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly ( RAPSODIA )

NCT06597383 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06597383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly ( RAPSODIA )
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
November 24, 2023
Completion date
November 30, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly